Understand the risk of bleeding from anticoagulation in atrial fibrillation
The HAS-BLED score was derived from a real-world cohort of 3978 with AF and assesses the 1-year risk for major bleeding (intracranial, hospitalization, hemoglobin decrease >2 g/L, and/or transfusion) associated with oral anticoagulation. Patients with a high risk of bleeding (HAS-BLED score ≥ 3) should undergo regular clinical review following the initiation of oral anticoagulation.
Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY.
The HAS-BLED score was derived from a real-world cohort of 3978 with AF and assesses the 1-year risk for major bleeding (intracranial, hospitalization, hemoglobin decrease >2 g/L, and/or transfusion) associated with oral anticoagulation. Patients with a high risk of bleeding (HAS-BLED score ≥ 3) should undergo regular clinical review following the initiation of oral anticoagulation.
Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY.
© 2020 QxMD Software Inc., all rights reserved. No part of this service may be reproduced in any way without express written consent of QxMD. This information should not be used for the diagnosis or treatment of any health problem or disease. This information is not intended to replace clinical judgment or guide individual patient care in any manner. Click here for full notice and disclaimer.
